Sun.Jul 23, 2023

article thumbnail

Statins reduce cardiovascular risk in people living with HIV, new global study finds

STAT

A statin a day reduces the risk of heart disease in younger people living with HIV, according to a new study published Sunday in the New England Journal of Medicine. “What the study is saying is if you add a statin treatment to antiretroviral therapy … that will now prevent to a large degree, the excess cardiovascular risk associated with HIV,” said Steven Grinspoon, lead author of the study, and a professor of medicine at Harvard Medical School.

article thumbnail

You’ve Failed Your Pharmacist Board Certification Exam…Now What?

Med Ed 101

I have received emails from pharmacists regarding board certification and inevitably, I get quite a few people looking for guidance on where to go next after they recently found out they failed their pharmacist board certification exam. We all face failures in life and it is natural to be sad. Make sure you really try […] The post You’ve Failed Your Pharmacist Board Certification Exam…Now What?

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biocon Biologics gets positive CHMP opinion for YESAFILI, biosimilar Aflibercept

Express Pharma

Biocon Biologics, a subsidiary of Biocon announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of YESAFILI, an aflibercept biosimilar. YESAFILI , an ophthalmology product, is intended for the treatment of neovascular (wet AMD) age-related macular degeneration, visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), visual impairment due to diabetic m

article thumbnail

Gilead drops magrolimab for myelodysplastic syndromes

pharmaphorum

Gilead drops magrolimab for myelodysplastic syndromes Phil.

95
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Strategies to Streamline & Optimize Formulation

PharmaTech

To support the growing need for nitrosamine testing, SGS has expanded its volume for nitrosamine testing beyond its current service offering in Mississauga, Canada. SGS has added capacity and instrumentation to offer nitrosamine testing, including drug substance-related impurities (NDSRIs) at its West Chester, PA and Markham, Canada laboratories to allow for expanded capacity for nitrosamine testing, while staying ahead of the curve as regulations continue to evolve.

52
article thumbnail

Teva’s smart inhaler launches in first European market

pharmaphorum

Teva’s smart inhaler launches in first European market Phil.

94

More Trending

article thumbnail

Switch study says patients prefer ViiV’s injectable HIV drug

pharmaphorum

Switch study says patients prefer ViiV’s injectable HIV drug Phil.

90
article thumbnail

New patent expiration for Sun Pharm drug WINLEVI

Drug Patent Watch

Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent expiration for Sun Pharm drug WINLEVI appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

A step-by-step guide to successful installation qualification (IQ)

GMPSOP

A step-by-step guide to successful installation qualification (IQ) Pharmaceuticals quality assurance & validation procedures GMPSOP A step-by-step guide to successful installation qualification (IQ) Last modified: July 23, 2023 Table of Contents Installation qualification (IQ) is one of the first tests during an equipment or system qualification.

article thumbnail

World-Leading CDMO Service

PharmaTech

To support the growing need for nitrosamine testing, SGS has expanded its volume for nitrosamine testing beyond its current service offering in Mississauga, Canada. SGS has added capacity and instrumentation to offer nitrosamine testing, including drug substance-related impurities (NDSRIs) at its West Chester, PA and Markham, Canada laboratories to allow for expanded capacity for nitrosamine testing, while staying ahead of the curve as regulations continue to evolve.

40
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Episode 837: Don’t Let IV Medications Shift A Patient Out of Ketosis

Pharmacy Joe

In this episode, I’ll discuss parenteral medication considerations for the ketogenic diet. Episode 837: Don't Let IV Medications Shift A Patient Out of Ketosis Subscribe on iTunes , Android , or Stitcher A high-fat, low-carbohydrate diet may be prescribed to induce ketosis and help patients with epilepsy that is refractory to medical treatment. While dietary carbohydrate intake is tightly controlled in these patients, small amounts of carbohydrate from non-dietary sources such as parenteral medi

article thumbnail

Responding to Symptoms

RX Note

Introduction Every day, community pharmacists have to respond to symptoms presented by patients and make some clinical decision for the minor ailments. However, there are some factors that make this particularly challenging for us. Poor knowledge and skill in differential diagnosis Lack of access to patient's medical history or full medications profile Some patients did not disclose sufficient history of presenting illness , due to poor health literacy, perceived lack of privacy, stigma and emba

article thumbnail

Which pharmaceutical companies have the largest patent portfolios?

Drug Patent Watch

A strong patent portfolio is at the core of branded pharmaceutical firms. Accordingly, one way to assess the relative strength of pharmaceutical firms is to compare their patent-counts. This chart… The post Which pharmaceutical companies have the largest patent portfolios? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Myths about Medico-marketing Copy Writing – Come, Let’s Bust Them

PharmaState Academy

Written By: Vivek Hattangadi When I started writing medico-marketing copy as a brand manager, for some unknown reason I felt that you need to be well qualified and highly educated in the English language with a Ph. D or D.Litt. (and I am just a science graduate who passed out with just 36.5 percent score). But very soon I realized that what you really need.

article thumbnail

Fast-Forward on a Time Machine – Exploring Pharma Marketing 2037

PharmaState Academy

Written By: Vivek Hattangadi Come, let us board the time machine which takes us ahead of our times. And lo! We landed in Mumbai on 12th July 2037. Let us see what is happening here. Shantanu, a brilliant product of a top B-school and a senior manager in a leading FMCG company from India is having his 33rd birthday bash at home. Suddenly he collapses.